Eunomia helps pharmaceutical and biotech teams plan Canadian compliance operations, connecting federal advertising requirements and industry commitments with provincial context, bilingual review planning and HCP engagement controls.
Discuss this service
Local expertise · Global delivery
For international pharma teams entering Canada, emerging biotechs preparing commercial activity and compliance leaders coordinating federal rules, provincial health systems and English and French materials.
Canada combines federal regulation of health product advertising with industry-code commitments, provincial and territorial rules, professional standards and institutional policies. Prescription drug advertising to the public is tightly restricted; Quebec has distinct French-language requirements.
From requirements to action
We can scope a market-readiness review, map activities to federal rules and applicable code commitments, and identify provincial, French-language or specialist questions requiring local review. Outputs can include a responsibility matrix, promotional workflow, HCP engagement and payment controls, disclosure checks, monitoring plan and action list. Eunomia identifies Karen Glade as its Global Compliance Business Partner for the United States and Canada; confirm scope and specialist support before engagement.
What we can take on
What this gives you
Canada requirements built into your global processes
Clear responsibilities for review and escalation
Local support without unnecessary fixed headcount
The rules in Canada
A short guide to the main legal and self-regulatory frameworks. Each summary links to its official source below.
The Food and Drugs Act and Regulations govern health product advertising. Health Canada states public prescription drug advertising is generally restricted to the drug's brand, proper or common name, price and quantity; further restrictions apply to certain diseases and products. HCP advertising is treated differently but remains subject to federal requirements.
Promotion is generally limited to products authorized for sale in Canada and must respect the terms of market authorization. Health Canada guidance distinguishes advertising from other activities, including scientific or medical information. Review purpose, audience, content and context before classifying digital, social, investor or disease-awareness communications.
The PAAB Code sets standards for advertising within its scope, including full, fair and balanced disclosure. Preclearance is a Code requirement for in-scope materials unless exempt; it is not universal statutory pre-approval. Health Canada can require preclearance in defined circumstances. Confirm the applicable route, language and review status.
The IMC Code guides member-company activities in commercializing prescription medicines. It is an industry commitment, not legislation automatically binding every company. Confirm membership or contractual adoption and translate applicable requirements into engagement, sponsorship, meal, education and review controls.
Canada has no single federal HCP payment register equivalent to US Open Payments. IMC publishes a voluntary disclosure framework for participating companies. Check provincial requirements separately: Ontario's enacted Health Sector Payment Transparency Act states that it comes into force on a date set by proclamation; verify current status before treating it as operative.
Health professional rules, privacy requirements and institution policies vary by province and territory. Quebec's Charter of the French Language requires commercial advertising to be in French; where another language is used, French must generally be markedly predominant, subject to exceptions. Plan French-language review and confirm application to each product, channel and audience.
This overview is informational and does not constitute legal advice. Scope and application should be confirmed for the organisation, market, activity and counterparty in question. Sources checked September 2026.
Questions, answered
Federal law generally restricts public prescription drug advertising to the brand, proper or common name, price and quantity. Disease and product-specific restrictions also apply.
No. It is a Code requirement for materials within the PAAB Code's scope unless exempt. Health Canada may require preclearance in defined cases.
There is no single federal HCP payment register equivalent to US Open Payments. IMC has a voluntary framework; provincial laws and status should be assessed separately. Ontario's 2017 Act says commencement is by proclamation.
This guide does not claim a Canadian office or formal regulatory appointment. Eunomia identifies Karen Glade as its Global Compliance Business Partner for the United States and Canada. Contact us to confirm expertise, French-language support and delivery arrangements.
We will listen, ask a few questions and recommend the right scope—without obligation or pressure.
Start a conversation